| Not Yet Recruiting | Preliminary Efficacy Analysis of "C" Single Flap Plasty Reconstruction After Laparoscopic Proximal Gastrectomy NCT06741501 | Daorong Wang | N/A |
| Recruiting | Preliminary Efficacy Analysis of 'λ+α' Double-Tract Reconstruction After Laparoscopic Proximal Gastrectomy NCT06475170 | Northern Jiangsu People's Hospital | N/A |
| Completed | FundoRing Roux-en-Y Gastric Bypass Versus FundoRing One Anastomosis Gastric Bypass NCT07486765 | The Society of Bariatric and Metabolic Surgeons of Kazakhstan | N/A |
| Not Yet Recruiting | Protocol for Comparing the Efficacy of Three Reconstruction Methods of the Digestive Tract After Proximal Gast NCT06062225 | Changzhi People's Hospital Affiliated to Changzhi Medical College | N/A |
| Unknown | Jinghua Weikang Capsule in the Treatment of Reflux Esophagitis NCT06056973 | The First Affiliated Hospital of Dalian Medical University | Phase 4 |
| Unknown | Treatment of Reflux With Sleeve Gastrectomy NCT06170060 | Yusuf Emre ALTUNDAL | N/A |
| Completed | Role of ARMA in Selective Subset of Refractory GERD Patients. NCT05899491 | Asian Institute of Gastroenterology, India | N/A |
| Unknown | A Study of Anaprazole Sodium Enteric-coated Tablets in the Treatment of Reflux Esophagitis NCT05604261 | Xuanzhu Biopharmaceutical Co., Ltd. | Phase 2 |
| Unknown | A Novel Endoloop Pre-test to Treat Gastroesophageal Reflux NCT05192538 | Affiliated Hospital to Academy of Military Medical Sciences | N/A |
| Completed | The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis NCT05813561 | Daewoong Pharmaceutical Co. LTD. | Phase 3 |
| Completed | The Phase III Clinical Trial of X842 Capsules for Reflux Esophagitis NCT07079540 | Jiangsu Sinorda Biomedicine Co., Ltd | Phase 3 |
| Unknown | Preliminary Efficacy Analysis of Cheng's Giraffe Reconstruction After Proximal Gastrectomy NCT04657848 | Zhejiang Cancer Hospital | N/A |
| Completed | Study to Evaluate the Safety and Efficacy of X842 in Patients With Reflux Esophagitis NCT04531475 | Jiangsu Sinorda Biomedicine Co., Ltd | Phase 2 |
| Completed | A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duod NCT03553563 | AstraZeneca | Phase 3 |
| Completed | Feasibility of Multi-Spectral Endoscopic Imaging for Detection of Early Neoplasia in Barrett's Oesophagus NCT03388047 | University of Cambridge | N/A |
| Completed | Vonoprazan Study of Investigating the Effect on Sleep Disturbance Associated With Reflux Esophagitis- Explorat NCT03116841 | Takeda | Phase 4 |
| Completed | Special Drug Use Surveillance of Vonoprazan for "Maintenance Therapy of Reflux Esophagitis: Long-term Use" NCT03214081 | Takeda | — |
| Completed | Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome NCT02513784 | Columbia University | N/A |
| Completed | Nexium Capsules S-CEI for Justification of Esomeprazole in Acid Related Disease for Reflux Symptom Healing Bas NCT02477475 | AstraZeneca | — |
| Terminated | Double Tract Anastomosis and Gastric Tube Anastomosis to Proximal Gastrectomy NCT02288728 | Jian-Kun Hu | N/A |
| Completed | BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subj NCT01964131 | AstraZeneca | Phase 1 |
| Completed | The Study to Evaluate Efficacy and Safety of Newrabell® Tab.(Rabeprazole Sodium) 10mg b.i.d in Refractory GERD NCT01860482 | Chong Kun Dang Pharmaceutical | Phase 4 |
| Completed | The Role of HIF-2a in the Pathogenesis of Reflux Esophagitis NCT01733810 | Dallas VA Medical Center | N/A |
| Completed | Study to Investigate the Safety, Tolerability and Efficacy of YH4808 in Patients With Reflux Esophagitis NCT01538849 | Yuhan Corporation | Phase 2 |
| Unknown | Adipokines and the Risk of Reflux Esophagitis NCT01560598 | Seoul National University Hospital | — |
| Completed | To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rab NCT01397084 | AstraZeneca | Phase 4 |
| Unknown | Incidence of Reflux Esophagitis After Pancreaticoduodenectomy NCT01311908 | National Taiwan University Hospital | — |
| Completed | The Efficacy of i-Scan for Detecting Reflux Esophagitis NCT01381991 | Konkuk University Hospital | N/A |
| Completed | Proton Pump Inhibitor (PPI) Therapy for Newly Diagnosed Esophagitis NCT00586963 | Mayo Clinic | — |
| Completed | Reflux Esophagitis Phase III Study (Maintenance Treatment) NCT00634114 | AstraZeneca | Phase 3 |
| Completed | Reflux Esophagitis Phase III Study (Initial Treatment) NCT00633932 | AstraZeneca | Phase 3 |
| Completed | Omepral® Tablets Special Clinical Experience Investigation in Patients With Erosive Esophagitis NCT00859287 | AstraZeneca | — |
| Completed | An Efficacy Study to Compare the Treatment Effects of Rabeprazole and Lansoprazole Depending on the Genotyping NCT01008696 | Janssen Korea, Ltd., Korea | Phase 4 |
| Completed | NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis NCT00206180 | AstraZeneca | Phase 4 |
| Unknown | 24 Hour Esophageal and Electrogastrography to Investigate the Mechanism of Reflux Esophagitis NCT00154570 | National Taiwan University Hospital | — |
| Unknown | Immunologic Factors in Reflux Esophagitis and Barrett's Esophagus NCT00155805 | National Taiwan University Hospital | — |